Fisher Scientific International Inc.Fisher Scientific International Inc.
2002 Annual ReportLetter to ShareholdersFisher At A GlanceQ & ALeadershipCorporate Information
Beyond ServiceBeyond BoundariesBeyond FulfillmentBeyond TechnologyFinancialsbacknext


Supplementary Information
Selected Financial Data
MD&A
Statement of Operations
Balance Sheet
Statement Of Cash Flows
Statement Of Changes in Stockholders Equity
Notes
Auditors' Report

NOTE 21 SEGMENT AND GEOGRAPHICAL FINANCIAL INFORMATION

The Company reports financial results on the basis of three business segments: domestic distribution, international distribution and laboratory workstations. The domestic distribution segment manufactures, sells and distributes products to three primary customer markets: scientific research, clinical laboratory and industrial safety. Additionally, this segment provides contract manufacturing, chemical manufacturing and custom chemical synthesis and pharmaceutical services for Phase III and Phase IV clinical trials. The international distribution segment sells and distributes products primarily to the scientific research market. The laboratory workstations segment engages in the manufacture and sale of laboratory furniture and fume hoods to the scientific research laboratory market and the manufacture and sale of consoles and enclosures to the technology, communication and financial markets.

Selected business segment financial information for the years ended December 31, 2002, 2001 and 2000 is presented below (in millions):



Income from operations is revenue less related direct and allocated expenses. External customer sales of the domestic distribution segment were $2,602 million, $2,281 million and $2,045 million during 2002, 2001 and 2000, respectively. Intercompany sales and transfers between segments were not material for 2002, 2001 or 2000.

The domestic distribution, international distribution and laboratory workstations segments accounted for $19.6 million, $6.5 million and $0.1 million, respectively, of the 2001 restructuring and other charges. In addition, the Company accelerated the vesting of common stock options and recorded a primarily noncash compensation charge of $33.5 million in 2001 not allocated by segment.

Total assets, capital expenditures and depreciation and amortization by segment for the year ended December 31 are as follows (in millions):



Sales outside the United States were approximately 18 percent, 17 percent and 19 percent of total sales in 2002, 2001 and 2000, respectively. No single foreign country accounted for more than 10 percent of sales during any of the years ended December 31, 2002, 2001 or 2000.

Long-lived assets and revenues by geographical area for the year ended December 31 are as follows (in millions):



backnext